|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR-ONB-17013394 |
|
最近更新日期: Date of Last Refreshed on: |
2017-11-15 11:37:45 |
|
注册时间: Date of Registration: |
2017-11-15 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
火针治疗稳定期白癜风自身对照临床研究 |
|
Public title: |
Clinical Observation of Fire Acupuncture in Treating Stable Vitiligo Self - control |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
火针治疗稳定期白癜风自身对照临床研究 |
|
Scientific title: |
Clinical Observation of Fire Acupuncture in Treating Stable Vitiligo Self - control |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
雒玉辉 |
研究负责人: |
雒玉辉 |
|
Applicant: |
Luo Yuhui |
Study leader: |
Luo Yuhui |
|
申请注册联系人电话: Applicant telephone: |
+86 18152020206 |
研究负责人电话:
Study leader's |
+86 18152020206 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
79251751@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
79251751@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
甘肃省兰州市七里河区瓜州路418号甘肃省中医院 |
研究负责人通讯地址: |
甘肃省兰州市七里河区瓜州路418号甘肃省中医院 |
|
Applicant address: |
418 Guazhou Road, Qilihe District, Lanzhou, Gansu, China |
Study leader's address: |
418 Guazhou Road, Qilihe District, Lanzhou, Gansu, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
甘肃省中医院 | |
|
申请人所在单位: |
甘肃省中医院 |
||
|
Applicant's institution: |
Gansu Provincial Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
Gansu Provincial Hospital of Traditional Chinese Medicine |
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2017-066-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
甘肃省中医院伦理委员会 |
||
|
Name of the ethic committee: |
Gansu Provincial Hospital of Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2017-11-10 00:00:00 | ||
|
伦理委员会联系人: |
李玉梅 |
||
|
Contact Name of the ethic committee: |
Li Yumei |
||
|
伦理委员会联系地址: |
甘肃省兰州市七里河区418号 |
||
|
Contact Address of the ethic committee: |
418 Qilihe District, Lanzhou, Gansu, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 0931-2687005 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
甘肃省中医院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Gansu Provincial Hospital of Traditional Chinese Medicine |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
甘肃省兰州市七里河区418号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
418 Qilihe District, Lanzhou, Gansu, China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
甘肃省中医院院内课题申请 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Gansu Provincial Hospital of Chinese medicine hospital application |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
稳定期白癜风 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Stable vitiligo |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
通过自身对照的试验方法,将同一位稳定期白癜风患者同一病损部位皮损分为实验组及常规对照组,对比观察火针及308nm准分子激光治疗稳定期白癜风的近期临床疗效,为临床治疗稳定期白癜风提供更多治疗方法。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Through self-control test method, the lesions of the same lesion in the same stable vitiligo patients were divided into experimental group and conventional control group. The clinical efficacy of fire needle and 308nm excimer laser in the treatment of stable vitiligo were compared. Vitiligo provides more treatment. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
(1)随机选取40例稳定期白癜风患者,告知试验目的,签署知情同意书;(2)设立自身对照,将40例稳定期白癜风患者每位患者的同一部位(如均为颈部、或躯干、或四肢部位)皮损,一处皮损设为观察部位(观察组),另一处皮损设为对照部位(常规对照组)。观察组皮损处常规消毒,予以一次性针灸针进行火针治疗,常规治疗对照组予以308准分子激光治疗(308准分子激光为目前治疗白癜风公认的有效常规治疗之一)。每周治疗一次,共治疗3个月,对比观察2组治疗的临床近期疗效。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
(1) randomly selected 40 patients with stable vitiligo, informed the purpose of the trial, signed informed consent; (2) set up their own control, the 40 patients with stable vitiligo in each patient in the same part of the body (such as the neck, or trunk , Or limbs) lesions, a lesion was set as the observation site (observation group), and another lesion as the control site (conventional control group). The lesions in the observation group were routinely disinfected, and disposable acupuncture needles were given fire needle treatment. The conventional treatment control group was given 308 excimer laser treatment (308 excimer laser is one of the effective conventional treatments recognized by the current treatment of vitiligo). Weekly treatment, a total of 3 months of treatment, compared the two groups observed the clinical short-term efficacy. |
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
同一病损部位(如均为颈部、或躯干、或四肢部位)至少有三处处于稳定期白癜风的患者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
The same lesion site (such as the neck, or trunk, or limbs) at least three in patients with stable vitiligo. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.进展期白癜风患者; 2.仅颜面部、掌跖、指(趾)部位痛阈值较低部位有皮损的白癜风患者;3.不能耐受火针治疗的白癜风患者;4.皮损处有溃疡、糜烂的白癜风患者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with advanced vitiligo; |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2017-11-01 00:00:00至 To 2018-11-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2017-11-01 00:00:00 至 To 2018-11-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
用现成的数据(研究对象顺序号)交替随机分配到实验组和对照组中去 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Randomly assigned to the experimental group and the control group with ready-made data (study subject sequence number) |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2019年11月11日通过课题原始资料共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
November 11, 2019 Raw data through the project share the original data |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case record sheet |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |